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INTRODUCTION:  Nephrogenic  diabetes  insipidus  occurs  in patients  on chronic  lithium  treatment  even
after  lithium  discontinuation.  Patients  affected  by  this  disorder  are  highly  vulnerable  to  hypernatremia
when  they  cannot  respond  to  their  thirst mechanism.  We  report  a rare  case  of hypernatremia  due  to
undiagnosed  nephrogenic  diabetes  insipidus  post  esophagectomy  in  a patient  with  remote  history of
lithium  use.
PRESENTATION  OF  CASE:  A 70-year-old  female  with  past  medical  history  of bipolar  disorder,  chronic
kidney  disease  and  pheochromocytoma  underwent  an  elective  esophagectomy  for  esophageal  adeno-
carcinoma.  Lithium  was  discontinued  10  years  prior  to  her  presentation.  She  was  kept nil per  os  post
operatively  and  subsequently  developed  altered  mental  status  necessitating  intubation.  Her  sodium  level
was  found  to be 156  mmol/L.  A water  deprivation  test  and  desmopressin  trial  confirmed  nephrogenic
diabetes  insipidus.  Days  after  dextrose  5% in  water  infusion,  free  water  flushes  through  the  jejunostomy
tube  and  hydrochlorothiazide,  her  hypernatremia  improved  slowly  with  subsequent  improvement  in  her
mental  status.
DISCUSSION:  Several  mechanisms  have  been  described  in literature  to explain  the  persistent  damage
caused  by  lithium  on  the kidneys.  When  patients  lose  access  to  a  source  of  free  water  and  are  resuscitated
with normal  saline  post operatively,  they  are  at risk  of developing  life-threatening  hypernatremia.  This
can be avoided  by  aggressive  hydration  with  appropriate  fluid  replacement.
CONCLUSION:  Surgeons  should  be  aware  of the  persistent  renal  defects  caused  by  long  term  lithium  use
and  development  of nephrogenic  diabetes  insipidus  even  years  after  medication  cessation.
© 2019  Published  by  Elsevier  Ltd on  behalf  of  IJS  Publishing  Group  Ltd.  This  is  an  open  access  article
under  the  CC  BY  license  (http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Diabetes insipidus, which is clinically characterized by polyuria
and polydipsia, is a disorder resulting from inadequate anti-
diuretic hormone (ADH) action. Nephrogenic diabetes insipidus
(NDI) occurs when there is normal ADH secretion but abnormal
renal response to its diuretic effect causing inability to concentrate
urine. NDI can be either hereditary or acquired due to hyper-
calcemia, obstructive uropathy, hypokalemia or drugs. Chronic
lithium use is considered one of the most common causes of NDI.
It is estimated that 12% of patients on chronic lithium treatment
Abbreviations: NDI, nephrogenic diabetes insipidus; ADH, anti-diuretic hor-
mone; NPO, nil per os; D5W, dextrose 5% in water; cAMP, cyclic adenosine
monophosphate.
∗ Corresponding author at: Department of Surgery, Henry Ford Hospital, Clara
Ford Pavilion, 2799 W Grand Blvd, Detroit, MI,  48202, USA.
E-mail address: hnasser2@hfhs.org (H. Nasser).
develop NDI [1]. Even after lithium discontinuation, some patients
are still at risk of developing NDI due to persistent renal concen-
trating defect [2]. This risk can be easily missed if physicians are
unaware of the remote history of lithium use. NDI can manifest
as a serious postoperative complication if fluid intake is restricted,
and the inappropriate intravenous fluids are administered. It is cru-
cial for surgeons to recognize NDI and initiate early therapy, as it
can lead to serious neurologic consequences. We  report a rare case
of hypernatremia due to undiagnosed NDI post esophagectomy in
a patient with remote history of lithium use. This case report has
been reported in line with the surgical case report (SCARE) criteria
[3].
2. Presentation of case
A 70-year-old female with past medical history of bipolar
disorder, chronic kidney disease and pheochromocytoma status
post adrenalectomy was  admitted to the hospital for an elective
esophagectomy for esophageal adenocarcinoma. Her bipolar dis-
https://doi.org/10.1016/j.ijscr.2019.03.006
2210-2612/© 2019 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/
by/4.0/).
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Table  1
Patient’s lab values and urine output postoperatively.
POD 0 1 2 3 4 5 6 7 8 9
SNa 141 145 156 155 156 153 152 150 142 140
SOsm 334 321 301
UOsm 299 209 219 211 224 192
UNa 85 51 65 76 72 42
UO  3410 2425 2700 4255 4080 3705 4000 2050 1350 1625
POD, postoperative day; SNa, serum sodium in mmol/L; SOsm, serum osmolarity
in  mOsm/kg H2O; UOsm, urine osmolarity in mOsm/kg H2O; UNa, urine sodium in
mmol/L; UO, urine output in mL  per day.
order was previously treated with lithium for 25 years but was
discontinued 10 years prior to her presentation.
The patient underwent robotic-assisted laparoscopic
esophagectomy and jejunostomy feeding tube insertion with
no significant complications. Post-operatively, she was kept nil
per os (NPO) and started on 0.9% sodium chloride infusion at a rate
of 75 ml/hour. She subsequently developed confusion, agitation,
anxiety and tremulousness. She pulled out her nasogastric tube
and attempted to pull out her peripheral intravenous lines. Blood
work revealed an increase in her serum sodium from 145 to
156 mmol/L and creatinine from 1.57 to 1.98 mmol/L within 24 h
with normal potassium level.
Intravenous 0.9% saline infusion was replaced by dextrose 5% in
water (D5W) infusion along with free water through the jejunos-
tomy tube with no significant improvement in her sodium level.
On post-operative day 3, the patient’s clinical status deteriorated.
She had significant mental status changes and was  found unre-
sponsive necessitating intubation for airway protection. She was
subsequently transferred to the surgical intensive care unit. Follow-
up labs showed persistently elevated sodium level at 155 mmol/L,
urine osmolarity of 299 mOsm/kg H2O and serum osmolarity of 334
mOsm/kg H2O (Table 1). She had a urine output of 4.2 L in 24 h. A
‘water deprivation test’ was done, the results of which were consis-
tent with diabetes insipidus. On post-operative day 5, a trial dose
of 4 g of intravenous desmopressin was administered with no sig-
nificant increase in urine osmolarity consistent with NDI (Table 1).
She was subsequently started on hydrochlorothiazide 25 mg  daily.
After a few days of free water flushes through the jejunostomy
feeding tube, D5W infusion and hydrochlorothiazide, the patient’s
sodium level started to improve slowly reaching 140 mmol/L on
post-operative day 9. D5W infusion was subsequently stopped and
free water flushes were adjusted to 300 mL  every 6 h. The patient’s
mental status improved gradually as her sodium level normalized.
She was extubated and transferred to a surgical step-down unit. She
was discharged on post-operative day 18. She was seen in clinic 4
months later where she denied polydipsia and polyuria and her
sodium level was 141 mmol/L.
3. Discussion
Lithium is one of the main maintenance treatment options for
bipolar disorder. It is used in up to 0.1% of the entire population
[2]. It is widely used despite its various renal side effects that
include chronic tubulointerstitial nephropathy, renal tubular aci-
dosis, hypercalcemia and NDI.
ADH or vasopressin binds to its V2 receptors on the princi-
pal cells of the collecting tubules leading to aquaporin-2 water
channels translocation and water reabsorption down a favorable
concentration gradient. Behl et al. described multiple mecha-
nisms by which lithium causes natriuresis and renal cellular
damage including interference with epithelial sodium channels
and increase in cyclooxygenase-2 and prostaglandin E2 expres-
sion in the cortical collecting tubules [4,5]. These described changes
explain the acute effect of lithium on the renal tubules but do not
explain the persistent concentrating defect after withdrawal of the
medication. Several mechanisms of persistent damage caused by
lithium have been studied in literature and include slow recov-
ery of aquaporin-2 gene expression after lithium cessation, loss
of renal medullary osmotic gradient and lithium-induced intersti-
tial nephritis that causes persistent renal insufficiency [6]. To note,
our patient did have a history of chronic kidney disease that was
attributed to lithium and could have contributed to her persistent
renal concentrating defect 10 years after stopping the medication.
Patients with lithium-induced NDI usually report a history of
polydipsia and polyuria and do not develop hypernatremia as long
as they are able to keep up with their renal water losses. When
these patients cannot respond to their thirst drive, they develop
hypernatremia with increased serum osmolality and decreased
urine osmolality because of the kidneys’ inability to concentrate
urine and maintain appropriate fluid balance. This is what hap-
pened to our patient who  was kept NPO after her surgery and
was resuscitated with 0.9% sodium chloride which gave an addi-
tional sodium load that the kidneys were unable to eliminate.
Interestingly, our patient underwent an adrenalectomy for a diag-
nosis of pheochromocytoma few months prior to this presentation
but did not develop hypernatremia because she had access to free
water post-operatively. Post-operative hypernatremia can be fatal.
Baraza et al. reported a case of a large bowel obstruction from sig-
moid adenocarcinoma that necessitated an urgent laparotomy with
hemicolectomy [7]. The patient developed hypernatremia reaching
185 mmol/L due to lithium-induced NDI and suffered a respira-
tory arrest. Hypernatremia from lithium-induced NDI has also been
reported in the literature after gastric banding and coronary artery
bypass [6,8].
The diagnosis of lithium-induced NDI depends on a detailed
history of current or remote lithium use, symptoms of polydip-
sia and polyuria and absence of other causes of NDI. Our patient
had no evidence of hypokalemia, hypercalcemia, or medication use
that might have led to NDI other than her remote lithium use.
Diabetes insipidus diagnosis is suggested by high serum sodium
concentration and low urine osmolality. A ‘water deprivation test’
usually confirms the diagnosis and patients’ inability to concentrate
urine. The test is abnormal when urine osmolality does not increase
after a period (usually 12 h) of depriving patients of water. Normal
patients have more than 100% increase in their urine osmolality. To
determine whether the diabetes insipidus is of nephrogenic or cen-
tral origin, 4 g of desmopressin subcutaneously or intravenously
should be administered. A less than 10% increase in urine osmo-
lality after desmopressin is consistent with NDI [2]. Hypo-osmolar
solutions are used to correct the water deficit and replace ongoing
water losses based on the calculated total body water deficits. Thi-
azide diuretics, amiloride and indomethacin are also used to correct
hypernatremia. Diuretics promote proximal tubular water reab-
sorption, and hence decreased free water transmission to the distal
collecting tubules where the urine concentrating defect is located.
Indomethacin inhibits prostaglandin which increases cAMP in the
collecting tubules and thus increase water reabsorption [2]. Unlike
central diabetes insipidus, treatment with desmopressin fails to
improve hypernatremia, serum osmolality and urine osmolality in
most cases [9].
Hypernatremia due to lithium-induced NDI is a rare but poten-
tially fatal post-operative complication. Surgeons should have a
high index of suspicion when patients with history of lithium use
develop hypernatremia and neurologic changes. A history of bipo-
lar disorder should entail a more detailed inquiry about lithium
use and symptoms of polyuria and polydipsia in the pre-operative
evaluation. This allows preemptive measures to avoid the possibly
detrimental complications of hypernatremia in the post-operative
period. It is crucial in such patients to have more frequent elec-
trolytes checks, more accurate urine output measures and closer
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monitoring of their neurologic status [6]. It is preferable that
patients at high risk of developing of hypernatremia due to lithium-
induced NDI be allowed access to free water as soon as it is clinically
appropriate to replace their ongoing water losses. Hypo-osmolar
solutions such as D5W or half normal saline should be the main-
tenance fluids of choice in the post-operative period instead of
normal saline that worsens hypernatremia. An early consultation
to nephrology service can be important, as other modalities can
be used to correct the hypernatremia and reverse any neurologic
changes.
4. Conclusion
Lithium is a common cause of nephrogenic diabetes insipidus.
Lithium’s concentrating defect can persist years after its cessation.
Hypernatremia due to NDI can be a major cause of morbidity and
mortality in the post-operative period when patients lose access
to free water. Surgeons need to be aware of lithium induced NDI
and the potential rapid onset of life threatening neurologic and
metabolic disorders. Worsening post-operative hypernatremia and
polyuria showed prompt early consideration of lithium-induced
NDI and aggressive rehydration with appropriate fluids to prevent
detrimental neurologic changes.
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